Principal Financial Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q3 2024

A detailed history of Principal Financial Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 173,092 shares of REGN stock, worth $128 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
173,092
Previous 170,264 1.66%
Holding current value
$128 Million
Previous $179 Million 1.68%
% of portfolio
0.11%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$1024.09 - $1201.76 $2.9 Million - $3.4 Million
2,828 Added 1.66%
173,092 $182 Million
Q2 2024

Jul 29, 2024
BUY
$883.2 - $1071.19 $1.64 Million - $1.98 Million
1,852 Added 1.1%
170,264 $179 Million
Q1 2024

Apr 29, 2024
BUY
$902.69 - $993.35 $34 Million - $37.4 Million
37,685 Added 28.83%
168,412 $162 Million
Q4 2023

Feb 07, 2024
SELL
$775.18 - $881.7 $486,813 - $553,707
-628 Reduced 0.48%
130,727 $115 Million
Q3 2023

Nov 02, 2023
SELL
$692.45 - $844.37 $1.16 Million - $1.41 Million
-1,672 Reduced 1.26%
131,355 $108 Million
Q2 2023

Aug 07, 2023
SELL
$700.03 - $830.35 $2.27 Million - $2.69 Million
-3,241 Reduced 2.38%
133,027 $95.6 Million
Q1 2023

May 09, 2023
BUY
$680.49 - $826.97 $1.1 Million - $1.33 Million
1,614 Added 1.2%
136,268 $112 Million
Q4 2022

Feb 09, 2023
SELL
$705.89 - $766.39 $6.9 Million - $7.49 Million
-9,777 Reduced 6.77%
134,654 $97.2 Million
Q3 2022

Nov 09, 2022
BUY
$573.97 - $724.32 $8.59 Million - $10.8 Million
14,963 Added 11.56%
144,431 $99.5 Million
Q2 2022

Aug 10, 2022
BUY
$548.35 - $738.84 $1.82 Million - $2.46 Million
3,323 Added 2.63%
129,468 $76.5 Million
Q1 2022

May 09, 2022
BUY
$595.12 - $698.43 $157,111 - $184,385
264 Added 0.21%
126,145 $88.1 Million
Q4 2021

Feb 09, 2022
SELL
$543.48 - $670.97 $1.31 Million - $1.62 Million
-2,415 Reduced 1.88%
125,881 $79.5 Million
Q3 2021

Nov 09, 2021
BUY
$574.03 - $680.96 $1.54 Million - $1.83 Million
2,682 Added 2.14%
128,296 $77.6 Million
Q2 2021

Aug 10, 2021
SELL
$472.8 - $558.54 $2.98 Million - $3.52 Million
-6,296 Reduced 4.77%
125,614 $70.2 Million
Q1 2021

May 10, 2021
SELL
$446.73 - $548.2 $4.45 Million - $5.47 Million
-9,970 Reduced 7.03%
131,910 $62.4 Million
Q4 2020

Feb 08, 2021
SELL
$478.3 - $607.98 $3 Million - $3.82 Million
-6,275 Reduced 4.24%
141,880 $68.5 Million
Q3 2020

Nov 06, 2020
SELL
$544.75 - $658.21 $1.97 Million - $2.38 Million
-3,617 Reduced 2.38%
148,155 $82.9 Million
Q2 2020

Aug 05, 2020
BUY
$493.32 - $643.92 $16.8 Million - $22 Million
34,093 Added 28.97%
151,772 $94.7 Million
Q1 2020

May 12, 2020
BUY
$336.18 - $494.43 $2.23 Million - $3.29 Million
6,645 Added 5.98%
117,679 $57.5 Million
Q4 2019

Feb 05, 2020
SELL
$274.13 - $376.51 $946,570 - $1.3 Million
-3,453 Reduced 3.02%
111,034 $41.7 Million
Q3 2019

Nov 13, 2019
BUY
$273.46 - $318.39 $448,200 - $521,841
1,639 Added 1.45%
114,487 $31.8 Million
Q2 2019

Aug 12, 2019
SELL
$299.6 - $414.82 $884,419 - $1.22 Million
-2,952 Reduced 2.55%
112,848 $35.3 Million
Q1 2019

May 10, 2019
BUY
$372.08 - $439.57 $264,920 - $312,973
712 Added 0.62%
115,800 $47.5 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $518,170 - $621,890
-1,543 Reduced 1.32%
115,088 $43 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $812,889 - $945,700
2,315 Added 2.03%
116,631 $47.1 Million
Q2 2018

Aug 13, 2018
BUY
$284.6 - $344.99 $125,793 - $152,485
442 Added 0.39%
114,316 $0
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $93,166 - $116,165
-295 Reduced 0.26%
113,874 $39.2 Million
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $748,460 - $980,785
2,087 Added 1.86%
114,169 $42.9 Million
Q3 2017

Nov 02, 2017
BUY
$431.38 - $504.0 $48.3 Million - $56.5 Million
112,082
112,082 $50.1 Million

Others Institutions Holding REGN

# of Institutions
1,531
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email